Physician
SVMHS Clinics
SVMHS Clinics was paid $34.15M by Medicaid between Jan 2018 and Nov 2024, across 316 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoSVMHS CLINICS
SALINAS, CA 93901
SALINAS, CA 93901
33aNPI1093158347assigned 04/16/2013
33bProvider typeCritical Care Medicine (Internal Medicine) Physician
28Total paid$34.15M
24GClaims1,010,943
24DCodes billed316
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Care Medicine (Internal Medicine) Physician providers in California
Rank by total paid#1 of 136
Median peer was paid$38K
This provider vs. median905×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 95,630 | $3.21M | |
| 2019 | 106,978 | $3.59M | |
| 2020 | 96,852 | $3.31M | |
| 2021 | 129,825 | $4.78M | |
| 2022 | 192,075 | $5.12M | |
| 2023 | 217,812 | $7.60M | |
| 2024incomplete | 171,771 | $6.54M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 149,645 | 143,304 | $9.06M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 113,478 | 109,321 | $3.85M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 5.2% | 50,549 | 23,549 | $1.78M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.4% | 11,641 | 11,608 | $1.50M |
| 59425 | 4.2% | 15,579 | 11,601 | $1.44M | |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.0% | 27,271 | 11,192 | $1.38M |
| 99223 | Prolong inpt eval add15 m | 3.0% | 10,676 | 10,584 | $1.03M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.0% | 8,063 | 8,056 | $697K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.9% | 18,742 | 5,957 | $650K |
| 99239 | Hospital discharge day management, more than 30 minutes | 1.8% | 10,859 | 10,773 | $609K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.7% | 5,488 | 4,659 | $566K |
| 99222 | Initial hospital care, per day, moderate complexity | 1.5% | 6,960 | 6,905 | $519K |
304 more codes
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.5% | 14,840 | $513K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.2% | 5,085 | $413K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 1.1% | 7,915 | $374K |
| 99243 | 1.1% | 3,164 | $359K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.0% | 15,795 | $342K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 2,911 | $330K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 54,425 | $308K |
| 76830 | Ultrasound, transvaginal | <1% | 2,724 | $253K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 3,080 | $236K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 2,285 | $231K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 33,028 | $219K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 5,086 | $199K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,897 | $180K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 5,897 | $180K |
| 11765 | <1% | 2,302 | $179K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 2,082 | $178K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 2,119 | $173K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 1,825 | $172K |
| 95811 | <1% | 1,703 | $163K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,652 | $153K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 5,832 | $149K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 4,774 | $145K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 10,376 | $144K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 796 | $140K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,652 | $136K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 5,589 | $134K |
| 64405 | <1% | 3,531 | $132K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 898 | $119K |
| 80061 | Lipid panel | <1% | 10,901 | $116K |
| 64615 | <1% | 1,409 | $114K | |
| 72141 | <1% | 1,489 | $114K | |
| 0001A | <1% | 2,852 | $110K | |
| 0002A | <1% | 2,722 | $108K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,477 | $103K |
| G9012 | Other specified case management service not elsewhere classified | <1% | 3,607 | $100K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 2,978 | $98K |
| 80053 | Comprehensive metabolic panel | <1% | 11,146 | $97K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,143 | $96K |
| 73221 | <1% | 1,029 | $96K | |
| 76642 | <1% | 3,432 | $96K | |
| 76801 | <1% | 1,293 | $95K | |
| 74178 | <1% | 606 | $94K | |
| 71045 | Radiologic examination, chest; single view | <1% | 17,516 | $94K |
| 11056 | <1% | 3,663 | $89K | |
| 64450 | <1% | 3,533 | $83K | |
| 11721 | <1% | 4,358 | $76K | |
| 76536 | <1% | 894 | $75K | |
| 90837 | Psychotherapy session, about an hour | <1% | 790 | $73K |
| 76770 | <1% | 1,147 | $72K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 408 | $72K |
| 95251 | <1% | 2,714 | $67K | |
| 93000 | <1% | 6,335 | $64K | |
| 73562 | <1% | 2,411 | $64K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,477 | $60K |
| 52000 | <1% | 394 | $60K | |
| 20610 | <1% | 2,777 | $59K | |
| 99242 | <1% | 730 | $59K | |
| 77066 | Tomosynthesis, mammo | <1% | 1,503 | $57K |
| 51700 | <1% | 1,618 | $57K | |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | <1% | 1,412 | $56K |
| 77049 | <1% | 326 | $55K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,416 | $54K |
| 73630 | <1% | 2,516 | $51K | |
| 84439 | <1% | 6,506 | $51K | |
| 17110 | <1% | 509 | $48K | |
| 72110 | <1% | 985 | $47K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 587 | $47K |
| 11750 | <1% | 358 | $47K | |
| 72197 | <1% | 272 | $43K | |
| 82962 | <1% | 30,151 | $42K | |
| 90686 | <1% | 2,432 | $41K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 310 | $40K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 2,916 | $39K |
| 93298 | <1% | 1,551 | $37K | |
| 73610 | <1% | 1,658 | $37K | |
| 99255 | <1% | 201 | $35K | |
| 71250 | <1% | 943 | $34K | |
| 97799 | <1% | 1,019 | $32K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,648 | $31K |
| 20552 | <1% | 1,137 | $31K | |
| 76870 | <1% | 474 | $30K | |
| 77065 | Tomosynthesis, mammo | <1% | 1,013 | $29K |
| 99426 | <1% | 549 | $29K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 653 | $28K |
| 73030 | <1% | 1,348 | $27K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,990 | $26K |
| 91320 | <1% | 199 | $24K | |
| 77062 | <1% | 1,014 | $23K | |
| 93296 | <1% | 2,861 | $23K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 568 | $23K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 345 | $22K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 409 | $22K |
| 0054A | <1% | 540 | $21K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 568 | $21K |
| 73564 | <1% | 906 | $20K | |
| 95816 | <1% | 413 | $20K | |
| 0004A | <1% | 490 | $20K | |
| 73130 | <1% | 939 | $19K | |
| 72100 | <1% | 838 | $19K | |
| 73110 | <1% | 774 | $18K | |
| 74018 | <1% | 1,886 | $18K | |
| 76882 | <1% | 433 | $17K | |
| 70496 | <1% | 314 | $17K | |
| 93970 | <1% | 487 | $16K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 538 | $16K |
| L3000 | Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | <1% | 73 | $16K |
| 70491 | <1% | 219 | $15K | |
| 73560 | <1% | 644 | $15K | |
| 92228 | <1% | 473 | $15K | |
| 82043 | <1% | 2,893 | $14K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 464 | $14K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,244 | $14K |
| 93018 | <1% | 1,704 | $14K | |
| 72050 | <1% | 299 | $14K | |
| 82951 | <1% | 1,309 | $14K | |
| 93971 | <1% | 776 | $14K | |
| 82570 | <1% | 2,951 | $13K | |
| 98926 | <1% | 337 | $13K | |
| 0012A | <1% | 318 | $13K | |
| 93294 | <1% | 1,386 | $13K | |
| 73502 | <1% | 558 | $12K | |
| 0124A | <1% | 303 | $12K | |
| 73100 | <1% | 384 | $12K | |
| 20550 | <1% | 318 | $12K | |
| 90480 | <1% | 301 | $12K | |
| 99497 | <1% | 273 | $12K | |
| 77061 | <1% | 507 | $11K | |
| 0011A | <1% | 334 | $11K | |
| 72040 | <1% | 488 | $11K | |
| 99245 | <1% | 108 | $11K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,677 | $11K |
| 83970 | <1% | 406 | $10K | |
| 0071A | <1% | 248 | $10K | |
| 70498 | <1% | 229 | $10K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 666 | $10K |
| G9920 | Screening performed and negative | <1% | 226 | $10K |
| 97802 | <1% | 80 | $10K | |
| 0072A | <1% | 235 | $9K | |
| 99460 | <1% | 129 | $9K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 878 | $8K |
| 51798 | <1% | 1,249 | $8K | |
| 99254 | <1% | 51 | $8K | |
| Z1034 | <1% | 142 | $7K | |
| 73140 | <1% | 385 | $7K | |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | <1% | 271 | $7K |
| 99152 | <1% | 671 | $7K | |
| 11900 | <1% | 134 | $7K | |
| 99205 | Prolong outpt/office vis | <1% | 121 | $6K |
| 73080 | <1% | 421 | $6K | |
| 76881 | <1% | 101 | $5K | |
| 90670 | <1% | 362 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,171 | $5K |
| 73590 | <1% | 415 | $5K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 224 | $5K |
| 0003A | <1% | 126 | $5K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,541 | $5K |
| 57288 | <1% | 18 | $5K | |
| 82728 | <1% | 443 | $5K | |
| 80076 | <1% | 798 | $5K | |
| 81025 | <1% | 1,653 | $5K | |
| 72072 | <1% | 137 | $5K | |
| 94060 | <1% | 252 | $5K | |
| 81001 | <1% | 1,716 | $4K | |
| 76813 | <1% | 33 | $4K | |
| 92250 | <1% | 102 | $4K | |
| 72131 | <1% | 98 | $4K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 66 | $4K |
| 11102 | <1% | 54 | $4K | |
| 84153 | <1% | 266 | $4K | |
| G9008 | Coordinated care fee, physician coordinated care oversight services | <1% | 42 | $4K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 506 | $4K |
| 93880 | <1% | 159 | $4K | |
| 84460 | <1% | 977 | $4K | |
| 81003 | <1% | 2,738 | $4K | |
| 90688 | <1% | 228 | $4K | |
| 76775 | <1% | 89 | $4K | |
| 11100 | <1% | 47 | $4K | |
| 29075 | <1% | 74 | $4K | |
| 83550 | <1% | 560 | $4K | |
| 0052A | <1% | 91 | $4K | |
| 83540 | <1% | 666 | $4K | |
| 99462 | <1% | 91 | $3K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,418 | $3K |
| 29065 | <1% | 57 | $3K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 320 | $3K |
| 73700 | <1% | 62 | $3K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 97 | $3K |
| 93295 | <1% | 266 | $3K | |
| 97165 | <1% | 69 | $3K | |
| 59025 | Fetal non-stress test | <1% | 90 | $3K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 507 | $3K |
| 90698 | <1% | 203 | $3K | |
| 90656 | <1% | 148 | $3K | |
| 77080 | <1% | 849 | $3K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 150 | $3K |
| 0051A | <1% | 64 | $3K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 23 | $3K |
| 83001 | <1% | 151 | $2K | |
| 85652 | <1% | 1,009 | $2K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 169 | $2K |
| 83721 | <1% | 318 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 27 | $2K |
| 90662 | <1% | 689 | $2K | |
| 74019 | <1% | 91 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 676 | $2K |
| 82607 | <1% | 211 | $2K | |
| 93016 | <1% | 144 | $2K | |
| 99358 | Prolong nursin fac eval 15m | <1% | 27 | $2K |
| 19083 | <1% | 13 | $2K | |
| 82550 | <1% | 386 | $2K | |
| 29405 | <1% | 38 | $2K | |
| 72146 | <1% | 21 | $2K | |
| 71101 | <1% | 84 | $2K | |
| 73620 | <1% | 78 | $2K | |
| 84146 | <1% | 105 | $2K | |
| 73120 | <1% | 79 | $2K | |
| 64402 | <1% | 23 | $1K | |
| 70486 | <1% | 32 | $1K | |
| 72170 | <1% | 86 | $1K | |
| 71271 | <1% | 32 | $1K | |
| 73090 | <1% | 107 | $1K | |
| 94729 | <1% | 97 | $1K | |
| 86140 | <1% | 254 | $1K | |
| 99307 | <1% | 305 | $1K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 76 | $1K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 478 | $985.26 |
| 90682 | <1% | 24 | $981.60 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 322 | $955.78 |
| 72070 | <1% | 54 | $947.51 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 23 | $937.47 |
| 73070 | <1% | 30 | $897.87 | |
| 73060 | <1% | 69 | $750.70 | |
| 82746 | <1% | 57 | $749.58 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 12 | $715.12 |
| 99385 | <1% | 108 | $684.60 | |
| 99000 | <1% | 184 | $674.09 | |
| 0053A | <1% | 15 | $600.00 | |
| 99386 | <1% | 74 | $594.90 | |
| 82670 | <1% | 25 | $556.80 | |
| 77001 | <1% | 50 | $541.37 | |
| 0082A | <1% | 13 | $520.00 | |
| 51702 | <1% | 18 | $461.03 | |
| 90715 | <1% | 12 | $457.20 | |
| 74181 | <1% | 12 | $444.96 | |
| 17000 | <1% | 12 | $442.86 | |
| 84075 | <1% | 134 | $431.29 | |
| 83002 | <1% | 29 | $420.76 | |
| 90680 | <1% | 30 | $400.50 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 43 | $396.00 |
| 87428 | <1% | 14 | $395.40 | |
| 84480 | <1% | 25 | $374.78 | |
| 82565 | <1% | 187 | $364.11 | |
| 90677 | <1% | 45 | $355.34 | |
| 90744 | <1% | 25 | $333.00 | |
| 83735 | <1% | 53 | $322.76 | |
| 94726 | <1% | 42 | $308.70 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 14 | $308.06 |
| 93299 | <1% | 76 | $306.22 | |
| 73660 | <1% | 30 | $272.94 | |
| 86431 | <1% | 56 | $269.72 | |
| 90658 | <1% | 12 | $263.20 | |
| 93244 | <1% | 12 | $248.00 | |
| 76937 | <1% | 29 | $237.57 | |
| 84550 | <1% | 68 | $236.75 | |
| 85610 | <1% | 171 | $184.03 | |
| 86580 | <1% | 54 | $159.95 | |
| 97162 | <1% | 26 | $159.48 | |
| 99406 | <1% | 12 | $156.20 | |
| 73552 | <1% | 13 | $155.98 | |
| 70360 | <1% | 15 | $127.46 | |
| 84450 | <1% | 28 | $126.00 | |
| 93280 | <1% | 13 | $121.23 | |
| 80050 | General health panel | <1% | 13 | $113.56 |
| 99442 | <1% | 17 | $110.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 13 | $94.77 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 14 | $85.56 |
| 36416 | <1% | 104 | $79.24 | |
| 99241 | <1% | 13 | $76.78 | |
| 71100 | <1% | 12 | $72.01 | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,008 | $52.00 |
| 99441 | <1% | 18 | $48.36 | |
| 81002 | <1% | 29 | $40.70 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 12 | $35.46 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 13 | $34.20 |
| G0127 | Trimming of dystrophic nails, any number | <1% | 42 | $33.08 |
| 1036F | <1% | 62,958 | $32.68 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 3,094 | $30.59 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 79 | $17.17 |
| 3078F | 0% | 9,255 | $0.00 | |
| 3046F | 0% | 2,962 | $0.00 | |
| 3077F | 0% | 2,813 | $0.00 | |
| 3051F | 0% | 3,278 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 29 | $0.00 |
| 99387 | 0% | 17 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 48 | $0.00 |
| 99221 | 0% | 24 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 12 | $0.00 |
| 3052F | 0% | 2,032 | $0.00 | |
| 3074F | 0% | 6,533 | $0.00 | |
| 3075F | 0% | 2,003 | $0.00 | |
| G8433 | Screening for depression not completed, documented patient or medical reason | 0% | 218 | $0.00 |
| 3079F | 0% | 2,638 | $0.00 | |
| 3044F | 0% | 7,794 | $0.00 | |
| 3080F | 0% | 654 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDELGADO, PEDRO (CEO)